• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制剂与高血压管理策略

ACE inhibitors and strategies for managing hypertension.

作者信息

Fuller R W

机构信息

Department of Clinical Pharmacology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Postgrad Med J. 1989;65 Suppl 1:S58-60.

PMID:2695911
Abstract

Angiotensin converting enzyme inhibitors are effective hypotensive agents, lowering blood pressure in patients with mild to moderate hypertension either alone or in combination with a low dose loop diuretic. They are generally well tolerated and score well in quality of life studies. However, in some patients they do cause cough, which may lead to their withdrawal, and their association with renal failure and death in elderly patients may reduce their usefulness in this age group. Nevertheless they have established a role as first line therapy in patients with asthma and diabetes.

摘要

血管紧张素转换酶抑制剂是有效的降压药物,可单独或与低剂量袢利尿剂联合使用,降低轻至中度高血压患者的血压。它们通常耐受性良好,在生活质量研究中得分较高。然而,在一些患者中,它们确实会引起咳嗽,这可能导致停药,而且它们与老年患者的肾衰竭和死亡有关,这可能会降低它们在该年龄组中的效用。尽管如此,它们已成为哮喘和糖尿病患者一线治疗药物。

相似文献

1
ACE inhibitors and strategies for managing hypertension.血管紧张素转换酶抑制剂与高血压管理策略
Postgrad Med J. 1989;65 Suppl 1:S58-60.
2
Angiotensin-converting enzyme inhibitors in the treatment of hypertension.血管紧张素转换酶抑制剂治疗高血压
J Cardiovasc Pharmacol. 1991;18 Suppl 7:S1-3.
3
[The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].[血管紧张素转换酶抑制剂在高血压治疗中的价值]
Z Kardiol. 1988;77 Suppl 3:73-88.
4
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用:我们能否做得更好?
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
5
Alternative first-line therapies in geriatric hypertension.
Geriatrics. 1989 Apr;44(4):61-4, 69-72, 74.
6
[Effects of angiotensin-converting enzyme inhibitors in hypertension].[血管紧张素转换酶抑制剂在高血压中的作用]
Z Kardiol. 1988;77 Suppl 3:69-71.
7
Angiotensin-converting enzyme inhibitors in hypertension: a review.血管紧张素转换酶抑制剂治疗高血压:综述
Int J Clin Pharmacol Res. 1985;5(6):429-38.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.原发性醛固酮增多症所致高血压中血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂:排除的理由。
Ann Pharmacother. 2007 Jan;41(1):129-32. doi: 10.1345/aph.1H456. Epub 2006 Dec 19.
9
Modulation of the renin-angiotensin-aldosterone system and cough.肾素-血管紧张素-醛固酮系统的调节与咳嗽
Can J Cardiol. 1995 Aug;11 Suppl F:33F-39F.
10
[Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].血管紧张素II拮抗剂与血管紧张素转换酶抑制剂治疗高血压的比较
Ugeskr Laeger. 2001 Dec 10;163(50):7036-9.